Vonage Brings Network Innovation to Mobile World Congress 2026

26.2.2026 09:33:00 CET | Business Wire | Press Release

Vonage, part of Ericsson (NASDAQ: ERIC), is set to make an impact at Mobile World Congress (MWC) 2026, the connectivity industry’s most influential exhibition, taking place March 2–5 in Barcelona. Vonage’s presence will include product demos, thought leadership sessions, and ecosystem collaborations, showcasing how the Company is leading the transformation of mobile networks into the enterprise platform of the future.

“The digital arena is undergoing a fundamental shift as mobile networks transform into platforms and redefine the enterprise technology stack,” said Neelam Sandhu, Chief Marketing Officer at Vonage. “Mobile World Congress is where possibilities turn into real-world applications, and we demonstrate the capabilities and intelligence embedded in mobile networks to developers and enterprises, showcasing how they are becoming engines of innovation for industries worldwide. I am excited for Vonage to be at the helm of the thought leadership conversation and to reveal our latest innovations alongside our partners across the ecosystem.”

Thought Leadership Sessions

Vonage executives will take centre stage and lead a series of keynotes and panels at MWC 2026, including:

AI in Motion: Reinventing Supply Chains
Monday, March 2 | 4:30 PM – 5:15 PM | Turing Stage, Hall 6
Vonage CEO, Niklas Heuveldop, and executives from Google Cloud, Kore Wireless, and Verizon, discuss why mobile networks are now a strategic layer of the enterprise tech stack.

The Scam Threat Landscape – The Currency of Trust
Tuesday, March 3 | 3:15 PM – 4:00 PM | Connected Industries, Hall 4
Vonage President of BU API, Christophe Van de Weyer, in conversation with AT&T, Apate.ai and NVIDIA, highlights how network powered solutions are redefining fraud prevention.

From Generative to Agentic: Powering Autonomous AI with Network Powered Solutions
Wednesday, March 4 | 10:35 AM – 10:50 AM | GSMA Open Gateway Summit, Partner Theatre 2
Vonage CMO, Neelam Sandhu, explores how high-performance, programmable connectivity will power agentic AI and redefine enterprise operations.

Fasten Your Seatbelts: How Vertical Industries Are Accelerating Network API Monetisation
Wednesday, March 4 | 12:40 PM – 12:55 PM | GSMA Open Gateway Summit, Partner Theatre 2
Speakers from Air Europa, CPaaS Acceleration Alliance, Turk Telkom, and Vonage, discuss new monetisation opportunities on mobile networks.

Accelerating Innovation Across the ICT Industry – A Collaborative Vision
Wednesday, March 4 | 2:30 PM – 3:30 PM | Ericsson Pavilion, Hall 2
Vonage CEO, Niklas Heuveldop, and executives from Accenture, C3 AI, Deutsche Telekom, and NVIDIA, examine the new enterprise value that is unlocked when industry pioneers unite behind the full potential of mobile networks.

Live Demonstrations

Attendees can experience Vonage innovations first-hand in the Ericsson Pavilion, Hall 2, at MWC 2026, showcasing the power of network APIs and the network powered solutions unlocking new value for developers and enterprises, including:

C3 AI Field Services Demo - A live demonstration of the C3 AI Field Services module integrated with the Vonage Quality on Demand (QoD) Network API and Vonage Communications APIs, equipping mobile workforces with advanced connectivity for superior performance, reliability, and experiences.

Zuper Platform and Zuper Glass - A showcase of Vonage Network APIs embedded within the Zuper platform, an AI operating system for the trades. With Vonage QoD, Zuper demonstrates how mobile network prioritisation enhances latency, reliability, and performance for mission-critical field workflows.

Always-On Connectivity with Vonage Messages API - Experience seamless, real-time communication with Rich Communication Services (RCS) and advanced messaging solutions, including WhatsApp, for always-connected customer engagement and conversational marketing.

Network Powered Fraud Protection - A look into how network powered solutions are transforming enterprise operations and customer experiences. Discover how Vonage Verify, Identity Insights, and Branded Calling provide cutting-edge fraud prevention, trusted connections, and secure authentication for businesses worldwide.

Vonage Contact Center - Discover how Vonage Contact Center empowers businesses with AI-driven, advanced customer experiences through deep CRM integrations, real-time insights, and intelligent automation.

AI-Powered Voice Agents - Experience the power of Vonage Voice API integrated with Amazon Nova Sonic – a next-generation speech-to-speech foundation model that enables enterprises to deploy real-time, natural-sounding AI voice agents.

Find out more about Vonage’s presence at MWC and book a meeting here.

About Vonage

Vonage, a part of Ericsson, creates technology that empowers enterprises and equips developers to lead in the next era of digital transformation. Its AI-powered platforms and tools enable new value creation and innovative customer experiences across mobile networks and the cloud.

The company's technology portfolio includes Network APIs, CPaaS, CCaaS, and UCaaS solutions. Trusted by enterprises across industries and embraced by developers around the world, Vonage is committed to reimagining every digital interaction.

Vonage is a wholly-owned subsidiary of Ericsson (NASDAQ: ERIC) and operates within Ericsson Group Business Area Global Communications Platform (BGCP). For more information visit www.vonage.com and follow @Vonage.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260226349606/en/

Contacts

Press Contact: press@vonage.com

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom